Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mutation | 4 | 2020 | 529 | 0.740 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2023 | 215 | 0.710 |
Why?
|
| Nuclear Proteins | 2 | 2020 | 79 | 0.700 |
Why?
|
| Chromatin | 1 | 2020 | 28 | 0.640 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2020 | 25 | 0.640 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 55 | 0.630 |
Why?
|
| Silymarin | 3 | 2015 | 39 | 0.510 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2016 | 1 | 0.500 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2017 | 273 | 0.500 |
Why?
|
| Interleukin-2 | 1 | 2016 | 40 | 0.500 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2016 | 66 | 0.490 |
Why?
|
| Liver Neoplasms | 2 | 2016 | 164 | 0.450 |
Why?
|
| Transport Vesicles | 1 | 2012 | 3 | 0.390 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 37 | 0.380 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 61 | 0.370 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 231 | 0.350 |
Why?
|
| Models, Biological | 2 | 2017 | 432 | 0.350 |
Why?
|
| Protein Binding | 2 | 2020 | 255 | 0.270 |
Why?
|
| Cell Proliferation | 4 | 2017 | 628 | 0.220 |
Why?
|
| Consanguinity | 1 | 2024 | 2 | 0.210 |
Why?
|
| Congenital Abnormalities | 1 | 2024 | 11 | 0.210 |
Why?
|
| Genetic Testing | 1 | 2024 | 99 | 0.200 |
Why?
|
| Apoptosis | 3 | 2017 | 400 | 0.200 |
Why?
|
| Cell Line, Tumor | 6 | 2017 | 772 | 0.190 |
Why?
|
| MicroRNAs | 2 | 2016 | 194 | 0.180 |
Why?
|
| Histones | 1 | 2020 | 53 | 0.160 |
Why?
|
| Binding Sites | 1 | 2020 | 150 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 86 | 0.160 |
Why?
|
| Humans | 11 | 2024 | 34497 | 0.150 |
Why?
|
| NF-kappa B | 2 | 2010 | 88 | 0.150 |
Why?
|
| Ovarian Neoplasms | 2 | 2017 | 114 | 0.150 |
Why?
|
| Quinazolinones | 1 | 2017 | 7 | 0.130 |
Why?
|
| Hep G2 Cells | 2 | 2016 | 28 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 91 | 0.130 |
Why?
|
| Orthopoxvirus | 1 | 2016 | 1 | 0.130 |
Why?
|
| Genes, MHC Class I | 1 | 2016 | 6 | 0.130 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2016 | 9 | 0.130 |
Why?
|
| Killer Cells, Natural | 1 | 2016 | 28 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 34 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 113 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 80 | 0.120 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 281 | 0.120 |
Why?
|
| Receptor, erbB-3 | 1 | 2015 | 2 | 0.120 |
Why?
|
| Neuregulin-1 | 1 | 2015 | 3 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 103 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2017 | 765 | 0.110 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2015 | 6 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 526 | 0.100 |
Why?
|
| Hepatitis B virus | 1 | 2013 | 6 | 0.100 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2013 | 16 | 0.100 |
Why?
|
| Genes, p53 | 1 | 2013 | 24 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2013 | 35 | 0.100 |
Why?
|
| Mice | 1 | 2016 | 2691 | 0.080 |
Why?
|
| Cathepsin B | 1 | 2010 | 1 | 0.080 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2009 | 3 | 0.080 |
Why?
|
| bcl-X Protein | 1 | 2009 | 6 | 0.080 |
Why?
|
| Arsenicals | 1 | 2009 | 13 | 0.080 |
Why?
|
| Oxides | 1 | 2009 | 18 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2009 | 35 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 72 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 153 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 152 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 155 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2010 | 161 | 0.070 |
Why?
|
| Male | 3 | 2024 | 20713 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2017 | 196 | 0.060 |
Why?
|
| Cell Movement | 2 | 2017 | 180 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 627 | 0.060 |
Why?
|
| Animals | 1 | 2016 | 8544 | 0.050 |
Why?
|
| Iran | 1 | 2024 | 6 | 0.050 |
Why?
|
| Prenatal Diagnosis | 1 | 2024 | 26 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2023 | 142 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2016 | 90 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2024 | 730 | 0.040 |
Why?
|
| Female | 4 | 2024 | 21499 | 0.040 |
Why?
|
| Infant | 1 | 2024 | 1122 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 399 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2024 | 1354 | 0.040 |
Why?
|
| Prognosis | 1 | 2023 | 1603 | 0.040 |
Why?
|
| Child | 1 | 2024 | 2614 | 0.030 |
Why?
|
| Cisplatin | 1 | 2017 | 88 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 304 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 41 | 0.030 |
Why?
|
| RNA Interference | 1 | 2016 | 79 | 0.030 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 12 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 175 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2015 | 55 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 82 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 281 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 328 | 0.030 |
Why?
|
| Antioxidants | 1 | 2015 | 126 | 0.030 |
Why?
|
| Cystatin A | 1 | 2010 | 8 | 0.020 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2010 | 6 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 43 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 10019 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 12 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2009 | 8 | 0.020 |
Why?
|
| Lipocalins | 1 | 2009 | 7 | 0.020 |
Why?
|
| Acute-Phase Proteins | 1 | 2009 | 11 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2009 | 8 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 43 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2009 | 22 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2009 | 43 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 44 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 56 | 0.020 |
Why?
|
| Sirtuin 1 | 1 | 2009 | 40 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2009 | 149 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2009 | 545 | 0.020 |
Why?
|